TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 163.00
-18.00 (-9.94%)
Jul 30, 2026, 11:16 AM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 10.69 billion as of July 29, 2026. Its market cap has increased by 160.06% in one year.
Market Cap
10.69B
Enterprise Value
10.11B
Revenue
703.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
163.00
ChartMarket Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 10.69B, an increase of 681.27%. That is a compound annual growth rate of 15.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 10.69B | 4.62% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.22B |
| Sunmax Biotechnology | 20.86B |
| TaiMed Biologics | 16.01B |
| Medigen Vaccine Biologics | 15.50B |
| Lumosa Therapeutics | 15.09B |
| Ever Supreme Bio Technology | 15.01B |
| EirGenix | 13.81B |
| ACRO Biomedical | 12.46B |